Knowledge and use of finasteride for the prevention of prostate cancer
RJ Hamilton, LC Kahwati, LS Kinsinger - Cancer epidemiology, biomarkers & …, 2010 - AACR
Background: The knowledge about and use of chemopreventive agents for prostate cancer
by physicians has not been described. The Prostate Cancer Prevention Trial (PCPT) …
by physicians has not been described. The Prostate Cancer Prevention Trial (PCPT) …
[引用][C] Finasteride for chemoprevention of prostate cancer: Is anyone buying it?
C Helwick - 2008
Update on chemoprevention for prostate cancer
SA Strope, GL Andriole - Current Opinion in Urology, 2010 - journals.lww.com
Dutasteride and finasteride are currently the only proven agents for prostate cancer risk
reduction. As potential modifiable risk factors are identified through epidemiologic and other …
reduction. As potential modifiable risk factors are identified through epidemiologic and other …
Abstract A071: Use of finasteride in the Prostate, Lung, Colorectal and Ovarian Cancer Prevention (PLCO) Trial cohort: Effects of sociodemographic factors and a …
JA Johnson, PF Pinsky - Cancer Epidemiology, Biomarkers & Prevention, 2020 - AACR
Abstract Background: In 1992, finasteride, a 5α-reductase inhibitor, was approved by the
Food and Drug Administration (FDA) for the treatment of benign prostatic hyperplasia (BPH) …
Food and Drug Administration (FDA) for the treatment of benign prostatic hyperplasia (BPH) …
[PDF][PDF] Outcomes Associated With the Use of Finasteride: An Evaluation of this Medication as a Chemoprotective Agent and its Efficacy
CH Cieslik - 2010 - dashboard.commons.pacificu.edu
Background: Whether a male should be placed on a well-studied pharmaceutical agent
thought to have chemoprotective properties, is currently a question that is debated by …
thought to have chemoprotective properties, is currently a question that is debated by …
Finasteride
UB Chaudhary, JS Turner - Expert Opinion on Drug Metabolism & …, 2010 - Taylor & Francis
Importance of the field: Prostate cancer is the most common non-cutaneous malignancy in
males in the US. Prostate cancer chemoprevention entails the use of agents which retard or …
males in the US. Prostate cancer chemoprevention entails the use of agents which retard or …
Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer?
D Greene, T Page - Nature Clinical Practice Urology, 2008 - nature.com
Background In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the
prevalence of prostate cancer compared with placebo; however, the proportion of high …
prevalence of prostate cancer compared with placebo; however, the proportion of high …
Use and knowledge of finasteride in the chemoprevention of prostate cancer: Trends in prescriptions and a survey of VA primary care physicians and urologists
R Hamilton - 2006 - cdr.lib.unc.edu
Background: Little is known about how physicians assimilate evidence regarding prostate
cancer prevention. Finasteride, a drug studied as a chemopreventive agent for prostate …
cancer prevention. Finasteride, a drug studied as a chemopreventive agent for prostate …
Using medicare claims to examine long-term prostate cancer risk of finasteride in the prostate cancer prevention trial
JM Unger, DL Hershman, C Till… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Investigators have used administrative claims to better understand cancer
outcomes when a research question cannot feasibly be examined within a study. The …
outcomes when a research question cannot feasibly be examined within a study. The …
An update on chemoprevention strategies in prostate cancer for 2006
MG Neill, NE Fleshner - Current opinion in urology, 2006 - journals.lww.com
Level one evidence exists for the preventative effects of finasteride in prostate cancer. The
evidence for other agents is less conclusive but a number of large-scale, appropriately …
evidence for other agents is less conclusive but a number of large-scale, appropriately …